333 related articles for article (PubMed ID: 3626003)
1. Generic drugs and the prescribing physician.
Nightingale SL; Morrison JC
JAMA; 1987 Sep; 258(9):1200-4. PubMed ID: 3626003
[TBL] [Abstract][Full Text] [Related]
2. Status of generic substitution: problematic drug classes reviewed.
Ross MB
Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356
[TBL] [Abstract][Full Text] [Related]
3. Prescription prices under the New York generic substitution law.
Francetić I; Lasagna L; Weintraub M; Karch FE
Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
[TBL] [Abstract][Full Text] [Related]
4. What makes a generic medication generic?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Dec; 47(12):17-20. PubMed ID: 20000278
[TBL] [Abstract][Full Text] [Related]
5. FDA drug list: key to generic substitution.
FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the bioavailability and bioequivalence of generic medications.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
[TBL] [Abstract][Full Text] [Related]
7. Product-line extensions and pricing strategies of brand-name drugs facing patent expiration.
Hong SH; Shepherd MD; Scoones D; Wan TT
J Manag Care Pharm; 2005; 11(9):746-54. PubMed ID: 16300418
[TBL] [Abstract][Full Text] [Related]
8. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
Bongiorno RA; Nutescu EA
Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
[TBL] [Abstract][Full Text] [Related]
9. Effect of generic drug competition on the price of prescription drugs in Ontario.
Lexchin J
CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888
[TBL] [Abstract][Full Text] [Related]
10. An overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations.
Knoben JE; Scott GR; Tonelli RJ
Am J Hosp Pharm; 1990 Dec; 47(12):2696-700. PubMed ID: 2278285
[TBL] [Abstract][Full Text] [Related]
11. The effects of competition on prescription-drug-product substitution.
Kralewski JE; Pitt L; Dowd B
N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
[TBL] [Abstract][Full Text] [Related]
12. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle.
Felch WC
Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131
[No Abstract] [Full Text] [Related]
13. Critical therapeutic categories: a contraindication to generic substitution?
Colaizzi JL; Lowenthal DT
Clin Ther; 1986; 8(4):370-9. PubMed ID: 3731208
[TBL] [Abstract][Full Text] [Related]
14. Teva v. Eisai: what's the real "controversy"?
Wang GL
Food Drug Law J; 2011; 66(4):631-54, iii. PubMed ID: 24505831
[TBL] [Abstract][Full Text] [Related]
15. Repercussions of the Drug Price Competition and Patent Term Restoration Act of 1984.
Hogan GF
Am J Hosp Pharm; 1985 Apr; 42(4):849-51. PubMed ID: 4014238
[TBL] [Abstract][Full Text] [Related]
16. Generic drugs: what are they?
Davies O
Sci Dig; 1978 Nov; 84(5):21-6. PubMed ID: 10238909
[No Abstract] [Full Text] [Related]
17. Strategies That Delay Market Entry of Generic Drugs.
Vokinger KN; Kesselheim AS; Avorn J; Sarpatwari A
JAMA Intern Med; 2017 Nov; 177(11):1665-1669. PubMed ID: 28975217
[TBL] [Abstract][Full Text] [Related]
18. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.
Gagne JJ; Polinski JM; Jiang W; Dutcher SK; Xie J; Lii J; Fulchino LA; Kesselheim AS
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):944-52. PubMed ID: 27102378
[TBL] [Abstract][Full Text] [Related]
19. A physician survey on generic drugs and substitution of critical dose medications.
Banahan BF; Kolassa EM
Arch Intern Med; 1997 Oct; 157(18):2080-8. PubMed ID: 9382664
[TBL] [Abstract][Full Text] [Related]
20. Regulating Generic Ophthalmologic Drug Bioequivalence-Envisioning Accessibility for Patients.
Luke MC; Kozak D
J Ocul Pharmacol Ther; 2021 Apr; 37(3):157-161. PubMed ID: 33332225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]